Wenjun Kang

764 citations
15 papers · 286 indexed · h-index 8
Topics
Neurological disorders and treatments (3 papers)Parkinson's Disease Mechanisms and Treatments (3 papers)Cancer Genomics and Diagnostics (3 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Wenjun Kang

15 papers receiving 280 citations

Peers

Wenjun Kang
Comparison fields: 5 of 64
  • Neurology 174
  • Cellular and Molecular Neuroscience 56
  • Molecular Biology 39
  • Physiology 37
  • Neurology 34
Replace Jorge Millán‐Pascual with:
Jorge Millán‐Pascual Spain
Ellen J. Spartz United States
Yoshihiko Furusawa Japan
R. Pfeiffer United States
Dongxue Ding China
Greta Brenna Italy
Olivia Schreiber‐Katz Germany
Barbora Srpová Czechia
Christopher A. Chow United States
Sophie Pittion France
Wenjun Kang relative to Jorge Millán‐Pascual Spain Jorge Millán‐Pascual's profile →
Citations per field
00.5×5.1×
Jorge Millán‐Pascual · 1×
Citations per year

Countries citing papers authored by Wenjun Kang

Since Specialization
Citations

This map shows the geographic impact of Wenjun Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Kang more than expected).

Fields of papers citing papers by Wenjun Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Kang. The network helps show where Wenjun Kang may publish in the future.

Co-authorship network of co-authors of Wenjun Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Kang. A scholar is included among the top collaborators of Wenjun Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Kang. Wenjun Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 1
3 1
4 25
5 10
6 7
7 3
8 2
9 4
10 15
11 3
12 53
13 9
14 27
15 124

About Wenjun Kang

Wenjun Kang is a scholar working on Cancer Research, Neurology and Anesthesiology and Pain Medicine, having authored 15 papers that have together received 286 indexed citations. Recurring topics across this work include Neurological disorders and treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Neurology (174 citations), Speech and Hearing (28 citations) and Neurology (34 citations). Wenjun Kang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Tao Xie, Peter C. Warnke, Un Jung Kang, Ellen MacCracken, Jacqueline Bernard, Arunas Gasparaitis, Joan Young, Mahesh Padmanaban, Abraham H. Dachman and Katerina Markopoulou. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026